Weeks after other Latin American countries began inoculating their citizens against coronavirus, Brazil finally administered its first shot on Jan. 17 using China's Sinovac Biotech Ltd vaccine.

With efficacy of just over 50% — barely above Brazil's threshold for regulatory approval — the Chinese shot was not the government's first choice. But for now, there is little else available.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.